For example, Arteaga et al. [49] reported that intraperitoneal injections of the murine TGF-β neutralizing antibody, 2G7 (Genentech®), was able to suppress lung metastases of MDA-MB-231 breast cancer cells that had been inoculated intraperitoneally. This evidence concerns the gene TGFB1 and breast cancer.